Cargando…
Molecular biomarkers in early stage lung cancer
Low dose computed tomography (LDCT) screening, together with the recent advances in targeted and immunotherapies, have shown to improve non-small cell lung cancer (NSCLC) survival. Furthermore, screening has increased the number of early stage-detected tumors, allowing for surgical resection and mul...
Autores principales: | Rodríguez, María, Ajona, Daniel, Seijo, Luis M., Sanz, Julián, Valencia, Karmele, Corral, Jesús, Mesa-Guzmán, Miguel, Pío, Rubén, Calvo, Alfonso, Lozano, María D., Zulueta, Javier J., Montuenga, Luis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947407/ https://www.ncbi.nlm.nih.gov/pubmed/33718054 http://dx.doi.org/10.21037/tlcr-20-750 |
Ejemplares similares
-
Editorial on implementation of CT-based screening of lung cancer
por: Rzyman, Witold
Publicado: (2021) -
Implementation of lung cancer screening: what are the main issues?
por: van der Aalst, Carlijn M., et al.
Publicado: (2021) -
Pulmonary nodule radiological diagnostic algorithm in lung cancer screening
por: Dziadziuszko, Katarzyna, et al.
Publicado: (2021) -
Implementation of low-dose CT screening in two different health care systems: Mount Sinai Healthcare System and Phoenix VA Health Care System
por: Henschke, Claudia I., et al.
Publicado: (2021) -
Overdiagnosis in lung cancer screening
por: Yankelevitz, David F., et al.
Publicado: (2021)